228 related articles for article (PubMed ID: 33281701)
1. Hypertrophic Pachymeningitis in a Southern Chinese Population: A Retrospective Study.
Xiao X; Fu D; Feng L
Front Neurol; 2020; 11():565088. PubMed ID: 33281701
[No Abstract] [Full Text] [Related]
2. Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course.
Bi Z; Shang K; Cao J; Su Z; Bu B; Xu S; Liu C
Biomed Res Int; 2020; 2020():2926419. PubMed ID: 32879880
[TBL] [Abstract][Full Text] [Related]
3. Distinct features of ANCA-associated hypertrophic pachymeningitis compared to other etiologies: findings from a study of 74 patients.
Martín-Nares E; Romero-Sánchez G; Cortez-Domínguez EU; Cano-Cruz LG; Hinojosa-Azaola A
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38759113
[TBL] [Abstract][Full Text] [Related]
4. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
Guan WJ; Ding YX; Liu LJ; Li W; Jing LJ; Zhang X; Zhang LJ; Li H; Cheng SH; Liu SY
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):565-569. PubMed ID: 35488609
[TBL] [Abstract][Full Text] [Related]
6. Imaging characteristics of hypertrophic pachymeningitis due to ANCA-associated vasculitis.
Takagi T; Okada M; Nakamura M; Hanari T; Nakata T; Teraoka M; Hato N
Auris Nasus Larynx; 2022 Oct; 49(5):875-879. PubMed ID: 35074241
[TBL] [Abstract][Full Text] [Related]
7. A nationwide survey of hypertrophic pachymeningitis in Japan.
Yonekawa T; Murai H; Utsuki S; Matsushita T; Masaki K; Isobe N; Yamasaki R; Yoshida M; Kusunoki S; Sakata K; Fujii K; Kira J
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):732-9. PubMed ID: 24273222
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.
Choi HA; Lee MJ; Chung CS
J Neurol; 2017 Apr; 264(4):724-732. PubMed ID: 28220286
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of the thickened dura mater impacting clinical signs in immune-mediated hypertrophic pachymeningitis.
Ikeda J; Shimojima Y; Yamada A; Sekijima Y
J Neurol Sci; 2023 Oct; 453():120780. PubMed ID: 37689000
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
11. IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.
Xia C; Li P
Front Neurol; 2022; 13():986694. PubMed ID: 36188377
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Shimojima Y; Kishida D; Hineno A; Yazaki M; Sekijima Y; Ikeda SI
Int J Rheum Dis; 2017 Apr; 20(4):489-496. PubMed ID: 28217942
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature.
Peng A; Yang X; Wu W; Xiao Z; Xie D; Ge S
Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):2915-2923. PubMed ID: 30328500
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of hypertrophic pachymeningitis in a center survey.
Cação G; Calejo M; Alves JE; Medeiros PB; Vila-Cha N; Mendonça T; Taipa R; Silva AM; Damásio J
Neurol Sci; 2019 Mar; 40(3):543-551. PubMed ID: 30588552
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic pachymeningitis.
Hahn LD; Fulbright R; Baehring JM
J Neurol Sci; 2016 Aug; 367():278-83. PubMed ID: 27423604
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analyses of perinuclear antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
Zhao P; Zhang BS
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):837-40. PubMed ID: 23859390
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic hypertrophic pachymeningitis: clinical, laboratory and neuroradiologic features in China.
Zhao M; Geng T; Qiao L; Shi J; Xie J; Huang F; Lin X; Wang J; Zuo H
J Clin Neurosci; 2014 Jul; 21(7):1127-32. PubMed ID: 24589555
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.
De Virgilio A; de Vincentiis M; Inghilleri M; Fabrini G; Conte M; Gallo A; Rizzo MI; Greco A
Immunol Res; 2017 Feb; 65(1):386-394. PubMed ID: 27592235
[TBL] [Abstract][Full Text] [Related]
19. Difficulties of diagnosing idiopathic hypertrophic pachymeningitis in children: Case report and literature review.
Nicho N; Nozawa T; Murase A; Hayashibe R; Tanoshima R; Okubo R; Hattori S; Nishimura K; Ohya T; Ito S
Mod Rheumatol Case Rep; 2023 Jan; 7(1):233-236. PubMed ID: 35348716
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic Pachymeningitis: An Unusual Cause of Headache.
Enabi J; Sharif MW; Venkatesan R; Kondakindi H; Faheem M
Cureus; 2024 Feb; 16(2):e53576. PubMed ID: 38445136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
